Susquehanna International Group’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Susquehanna International Group’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55	Closed	-$3.36K	–	13015
2024 Q2	$3.36K	Sell	55 -1	-2%	-$63	﹤0.01%	11833
2024 Q1	$3.54K	Buy	+56	New	+$6.24K	﹤0.01%	11968

Other funds holding SXTP

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SHF

Safe Harbor Fiduciary Pensacola, Florida $105M AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's SXTP Position: Q3 2024 in Review

Susquehanna International Group sold out of 60 Degrees Pharmaceuticals (SXTP) in Q3 2024, closing a stake of 55 shares — an estimated $3.36K sold.

Susquehanna International Group first reported a position in SXTP in Q1 2024 and held it in 2 quarters. The position peaked at $3.54K in Q1 2024. 6 funds tracked by Wall St. Rank hold SXTP as of Q3 2024.

Susquehanna International Group reported no remaining 60 Degrees Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 55 60 Degrees Pharmaceuticals shares in Q3 2024, an estimated $3.36K.
Susquehanna International Group first reported a position in 60 Degrees Pharmaceuticals in Q1 2024 and held it in 2 quarters.
Susquehanna International Group's 60 Degrees Pharmaceuticals position peaked at $3.54K in Q1 2024.
6 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.